Showing 1931-1940 of 3038 results for "".
- Bausch Health Licenses Novaliq’s NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunctionhttps://modernod.com/news/bausch-health-licenses-novaliqs-nov03-investigational-treatment-for-dry-eye-disease-associated-with-meibomian-gland-dysfunction/2477185/Bausch Health Companies and Novaliq have announced that Bausch Health has acquired an exclusive license for the commercialization and development in the United States and Canada of the investigational treatment NOV03 (perfluorohexy
- Novartis Receives Positive CHMP Opinion for Beovu (Brolucizumab) for the Treatment of Wet AMDhttps://modernod.com/news/novartis-receives-positive-chmp-opinion-for-beovu-brolucizumab-for-the-treatment-of-wet-amd/2477172/Novartis announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for Beovu (brolucizumab 6 mg), also known as RTH258, an investigational product for the treatment of wet age-related macular degeneration (AMD).<
- Eylea Injection Prefilled Syringe Now Availablehttps://modernod.com/news/eylea-injection-prefilled-syringe-now-available/2477154/Regeneron announced that the Eylea (aflibercept) prefilled syringe is now available for doctors to order. The 2 mg, single-dose, sterilized prefilled syringe provides physicians with a new way to administer Eylea that requires fewer preparation steps compared to vials. Eylea is the
- Retina Rocks: Retina Image & Reference Library Now Available Onlinehttps://modernod.com/news/retina-rocks-retina-image-reference-library-now-available-online/2477152/Retina Rocks, a new online, collection of open-source retina teachings, is now available at retinarocks.org. The website includes 22,000 multimodal images and 3,700 annotated references that are organized alphabetically by topic into approximately 360 sections
- Vision Innovation Partners Completes Acquisitions in Northern Marylandhttps://modernod.com/news/vision-innovation-partners-completes-acquisitions-in-northern-maryland/2477150/Vision Innovation Partners has announced it has acquired two practice groups and a surgery center in northern Maryland. The acquisition of Carroll Vision Center, Center for Total Eye Care, and Carroll County Surgery Center further expands Vision Innovation Partner
- Novartis Harnessing AI in Amazon Partnership Aimed at Revamping Drug Manufacturing, Supplyhttps://modernod.com/news/novartis-harnessing-ai-in-amazon-partnership-aimed-at-revamping-drug-manufacturing-supply/2477142/Novartis announced Wednesday that it will work with Amazon’s cloud-computing unit to build a data and analytics platform that seeks to “re-invent” the way medicines are manufactured and delivered. “Four years ago, we started our journey with AWS (Amazon Web Servi
- Senate Panel Advances Trump’s Nominee for FDA Commissionerhttps://modernod.com/news/senate-panel-advances-trumps-nominee-for-fda-commissioner/2477137/A Senate panel on Tuesday advanced President Donald Trump’s nomination of Dr. Stephen Hahn to be the next Food and Drug Administration commissioner, according to a CNBC report. The
- NovaBay Pharmaceuticals Launches NovaWipes Eyelid Wipes on Amazon.comhttps://modernod.com/news/novabay-pharmaceuticals-launches-novawipes-eyelid-wipes-on-amazon-com/2477129/NovaBay Pharmaceuticals announced the launch of NovaWipes, a dry, soft, hypoallergenic and absorbable wipe for use in applying Avenova, on Amazon.com. Avenova Direct, NovaBay’s prescription-strength lid and lash spray, is also available on Amazon.com without a prescription. “Our soft and a
- Novartis to Acquire The Medicines Company for $9.7 Billionhttps://modernod.com/news/novartis-to-acquire-the-medicines-company-for-9-7-billion/2477118/Novartis confirmed Sunday that it has agreed to buy The Medicines Company for $85 per share in cash, or roughly $9.7 billion on a fully diluted equity basis, gaining the RNAi-based PCSK9 inhibitor inclisiran. Rumors initially surfaced last week that Novartis was looking to acquire the c
- Report: Novartis Weighing Takeover Offer for The Medicines Companyhttps://modernod.com/news/report-novartis-weighing-takeover-offer-for-the-medicines-company/2477107/Novartis is considering making an offer to acquire The Medicines Company and is currently conducting due diligence on the drugmaker, Bloomberg reported Tuesday, citing people close to the matter. The sources suggested that The Medicines Company, which has a market value of about $4.7 bi